Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Maria L. Agostini(VIR Biotechnology (United States)), Mark R. Denison(Bipar), Robert Jordan(Gates Foundation), Ralph S. Baric(University of North Carolina at Chapel Hill), Joy Y. Feng(Gilead Sciences (United States)), Rachel L. Graham(University of North Carolina at Chapel Hill), Tomáš Cihlář(Gilead Sciences (United States)), Adrian S. Ray(Maine Farmland Trust), James Brett Case(Washington University in St. Louis), Michael O. Clarke(Gilead Sciences (United States)), Xiaotao Lu(Vanderbilt University Medical Center), Amy Sims(Georgia State University), Everett Clinton Smith(Sewanee: The University of the South), Dustin S. Siegel(Gilead Sciences (United States)), Timothy P. Sheahan(University of North Carolina at Chapel Hill), Erica L. Andres(Vanderbilt University Medical Center), Richard L. Mackman(Gilead Sciences (United States))
Cited by 1,519
Related Papers
Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking
|Nature Biotechnology|2016|4.7k
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
|Nature Communications|2020|1.8k
Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group
|Journal of Virology|2013|1.3k
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
|Proceedings of the National Academy of Sciences|2017|1.2k